Literature DB >> 22738613

Bone and joint infections in hospitalized patients in France, 2008: clinical and economic outcomes.

L Grammatico-Guillon1, S Baron, S Gettner, A-I Lecuyer, C Gaborit, P Rosset, E Rusch, L Bernard.   

Abstract

BACKGROUND: Adult bone and joint infections (BJIs) often require repeated and prolonged hospitalizations and are considered as a serious public health issue. AIM: To describe the epidemiology and economical outcomes of BJI in France.
METHODS: BJI hospitalizations with selected demographic, medical, and economic parameters from the French national hospital database for the year 2008 were identified. Overall patient characteristics and hospital stays for BJI underwent univariate analysis. Risk factors for device-associated infections were identified using multiple logistic regression modelling.
FINDINGS: Of all hospitalizations in France, 0.2% were BJI-related, representing 54.6 cases per 100,000 population, with a higher prevalence in males (sex ratio: 1.54). BJIs were more often native (68%) than device-associated (32%). The mean age was 63.1 years. Only 39% of hospital discharges had microbiological information coded; Staphylococcus spp. were isolated in 66% of those cases. Obesity, Staphylococcus spp., male sex and age >64 years were important risk factors for device-associated infections, whereas diabetes and ulcer sores were significantly associated with native infections. The case fatality was 4.6%. Intensive care unit stays were needed in 6% of cases. Readmissions to hospital occurred in 19% of cases, with significantly longer stays for device-associated infections than for native BJIs (18.9 vs 16.8 days). The cost of BJIs was €259 million, or about €7,000 per hospitalization in 2008.
CONCLUSIONS: This is the largest BJI study to date. The high economic burden of BJIs was mostly associated with more frequent and prolonged hospitalizations, high morbidity, and complexity of care.
Copyright © 2012 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22738613     DOI: 10.1016/j.jhin.2012.04.025

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  38 in total

1.  How to save time in surveillance without losing quality: comparison of two methods of surgical site infection surveillance in orthopaedic prosthetics in a French university hospital.

Authors:  Elisabetta Kuczewski; Elodie Munier-Marion; Sélilah Amour; Thomas Bénet; Frédéric Rongieras; Olivier Monneuse; Philippe Vanhems
Journal:  J Infect Prev       Date:  2020-07-20

2.  Susceptibility Pattern of Microorganisms Isolated by Percutaneous Needle Biopsy in Nonbacteremic Pyogenic Vertebral Osteomyelitis.

Authors:  Sophie Desoutter; Jean-Philippe Cottier; Idir Ghout; Bertrand Issartel; Aurélien Dinh; Arnaud Martin; Robert Carlier; Louis Bernard
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

Review 3.  Bone and joint infections due to anaerobic bacteria: an analysis of 61 cases and review of the literature.

Authors:  G Walter; M Vernier; P O Pinelli; M Million; M Coulange; P Seng; A Stein
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-28       Impact factor: 3.267

4.  How Many Samples and How Many Culture Media To Diagnose a Prosthetic Joint Infection: a Clinical and Microbiological Prospective Multicenter Study.

Authors:  Pascale Bémer; Julie Léger; Didier Tandé; Chloé Plouzeau; Anne Sophie Valentin; Anne Jolivet-Gougeon; Carole Lemarié; Marie Kempf; Geneviève Héry-Arnaud; Laurent Bret; Marie Emmanuelle Juvin; Bruno Giraudeau; Stéphane Corvec; Christophe Burucoa
Journal:  J Clin Microbiol       Date:  2015-12-04       Impact factor: 5.948

5.  Efficacy and safety of clindamycin-based treatment for bone and joint infections: a cohort study.

Authors:  J Courjon; E Demonchy; E Cua; E Bernard; P-M Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-09-07       Impact factor: 3.267

6.  Hypokalemia during antibiotic treatment for bone and joint infections.

Authors:  Carmen Falcone; Leonida Compostella; Antonella Camardo; Li Van Stella Truong; Francesco Centofanti
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-10-10

7.  Bone mineral density in osteoporotic patients with pyogenic vertebral osteomyelitis: effect of early versus late treatment for osteoporosis.

Authors:  J Kim; S W Kim; S Y Lee; T-H Kim; J-H Jung
Journal:  Osteoporos Int       Date:  2018-09-17       Impact factor: 4.507

8.  Antimicrobial-related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureus.

Authors:  Florent Valour; Judith Karsenty; Anissa Bouaziz; Florence Ader; Michel Tod; Sébastien Lustig; Frédéric Laurent; René Ecochard; Christian Chidiac; Tristan Ferry
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

9.  A retrospective cohort study comparing clinical outcomes and healthcare resource utilisation in patients undergoing surgery for osteomyelitis in England: a case for reorganising orthopaedic infection services.

Authors:  Jamie Ferguson; Myriam Alexander; Stuart Bruce; Matthew O'Connell; Sue Beecroft; Martin McNally
Journal:  J Bone Jt Infect       Date:  2021-04-28

Review 10.  Challenging Methicillin Resistance Detection in Bone and Joint Infections: Focus on the MRSA/SA SSTI® Strategy.

Authors:  Marie Titécat; Caroline Loïez; François Demaeght; Jean-Thomas Leclerc; Théo Martin; Hervé Dezèque; Henri Migaud; Eric Senneville
Journal:  Front Med (Lausanne)       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.